Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
9.57
-0.05 (-0.52%)
Jun 11, 2026, 11:29 AM CST
SHA:603998 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:603998 stock has a consensus rating of "Strong Buy" and an average price target of ¥15.32. The average 1-year stock price forecast is 60.08% higher than the current stock price, while the lowest is ¥14.00 (+46.29%) and the highest is ¥16.64 (+73.88%).
Price Target: ¥15.32 (+60.08%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:603998 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
1.96B
from 1.75B
Increased by 12.46%
Revenue Next Year
2.11B
from 1.96B
Increased by 7.26%
EPS This Year
0.82
EPS Next Year
n/a
from 0.82
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.0B | ||
| Avg | 2.0B | ||
| Low | 2.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.5% | ||
| Avg | 12.5% | ||
| Low | 12.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.82 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 173.2% | ||
| Low | - |